Follow the 오스테오닉 stock price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares trade on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 오스테오닉 has published 88 public disclosures. Market capitalisation: €99bn. The latest transaction was disclosed on 8 June 2026 (Purchase). Among the most active insiders: 이동원. The full history is accessible without an account.
87
Insider Decl.
n/a
Thresholds
n/a
9 ops.
Buy Volume
n/a
6 ops.
Sell Volume
19Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 5,383 of 29,055 companies
67.7
score / 100
Value
65
Quality
71
FCF yld0.1%
Earn yld8.6%
EV/EBITDA8.2x
ROE15%
Gross mgn49%
Net mgn17%
Debt/EBITDA1.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Osteonic es una empresa que opera en el sector de la salud y farmacéutico, cotiza en el mercado XKRX. Se especializa en el desarrollo de soluciones innovadoras para el tratamiento de enfermedades óseas.